𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab

✍ Scribed by Thomas Elter; Janne J. Vehreschild; John Gribben; Oliver A. Cornely; Andreas Engert; Michael Hallek

Publisher
Springer
Year
2008
Tongue
English
Weight
221 KB
Volume
88
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Alemtuzumab as treatment for residual di
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
✍ Susan M. O'Brien; Hagop M. Kantarjian; Deborah A. Thomas; Jorge Cortes; Francis πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to investigate the efficacy and safety of alemtuzumab, the humanized anti‐CD52 monoclonal antibody, in patients with B‐cell chronic lymphocytic leukemia and residual disease after chemotherapy. ## METHODS Forty‐one patients received alemt

Early treatment of high-risk chronic lym
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab
✍ Clive S. Zent; Timothy G. Call; Tait D. Shanafelt; Renee C. Tschumper; Diane F. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract ## BACKGROUND. Patients with chronic lymphocytic leukemia (CLL) usually are treated only for progressive disease. However, the discovery of biologic predictors of a high risk of disease progression, together with the development of newer, more targeted therapies, could change this para

P160 Alemtuzumab-induced apoptosis in vi
P160 Alemtuzumab-induced apoptosis in vitro in chronic lymphocytic leukemia with p53 deletion
✍ L. MΓ©hes; B. Telek; L. RejtΓΆ; A. Kiss; A. Ujfalusi; M. Udvardy πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 46 KB

lymphocytic leukemia. Besides establishing the demographic characteristics of 322 CLL cases studied, CD38 and ZAP7o was investigated in 58 vs. 64% of the cases while in 57% of the CLL cases FISH analysis for +12,13q ,11q and 17p was possible. Results: (1) The frequency of FISH detected aberrations i